Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2002-01-11
2004-05-25
Benzion, Gary (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024300, C530S350000, C435S320100, C435S325000
Reexamination Certificate
active
06740743
ABSTRACT:
FIELD OF THE INVENTION
This invention is in the field of molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding scorpion toxins that are potassium channel modifiers.
BACKGROUND OF THE INVENTION
Scorpion venoms have been recognized as a source of peptidyl inhibitors of various types of potassium ion (K) channels. Some of these peptides have been purified to homogeneity and their properties characterized. The most extensively studied of these toxins is charybdotoxin (ChTX). ChTX is a thirty-seven amino acid peptide isolated from venom of the old world scorpion
Leiurus quinquetriatus
var.
hebraeus
. Originally described as an inhibitor of the high-conductance, Ca
+2
-activated K (Maxi-K) channel present in muscle and neuro-endocrine cells, ChTX was later found to also inhibit a number of different medium- and small-conductance Ca
+2
-activated K-channels, as well as a voltage-dependent K-channel (K(v) 1.3). In each case, channel inhibition occurs with similar potency, in the low nanomolar range. A related toxin, iberiotoxin (IbTX), shares 68% sequence homology with ChTX and selectively blocks the Maxi-K channel. Other peptidyl inhibitors, such as limbatustoxin (LbTX) and kaliotoxin (KTX), have also been shown to possess greater selectivity for the Maxi-K channel. Other peptidyl toxins homologous to ChTX have been identified (e.g., noxiustoxin).
Potassium channels modulate a number of cellular events such as muscle contraction, neuro-endocrine secretion, frequency and duration of action potentials, electrolyte homeostasis, and resting membrane potential. These channels comprise a family of proteins that have been classified according to their biophysical and pharmacological characteristics. Inhibition of K-channels, in their role as modulators of the plasma membrane potential in human T-lymphocytes, has been postulated to play a role in eliciting immunosuppressive responses. In regulating membrane potential, K-channels play a role in the regulation of intracellular Ca
+2
homeostasis, which has been found to be important in T-cell activation.
Potassium channel modifiers are small polypeptides (31 to 37 amino acids) which form compact structures kept rigid by three disulfide bridges. Use of synthetic analogs with point mutations has determined that single amino acids residues are important for receptor binding and for biological activity of K-channel toxins (Sabatier et al. (1994)
Int. J. Peptide Protein Res.
43:486-495). Moreover, a drug with high affinity for the receptor could be expected to produce irreversible blockade of synaptic transmission. When labeled with a tracer molecule, such a drug would provide a reliable way of tagging receptors to permit measurement of their number and distribution within cells and tissues. These features would have very valuable consequences for research on excitatory amino acid neurotransmission and for the development of therapeutic agents to treat central nervous system dysfunction in humans and animals. Methods for treating heart and neurological diseases by applying toxins derived from spiders have been described (U.S. Pat. No. 4,925,664).
Arthropod animals, including insects, and certain parasitic worms, use excitatory amino acids as a major chemical neurotransmitter at their neuromuscular junction and in their central nervous system. Because of the damage done by insect pests and the prevalence of parasitic worm infections in animals and humans in many countries, there is a constant need for potent and specific new pesticides and anthelmintic drugs that are non-toxic to humans, pets, and farm animals.
Many arthropods produce a mixture of insecticidal proteins referred to as venom. These toxic substances are synthesized in specialized glandular tissues, which, when directed by a stinging or piercing apparatus, are capable of paralyzing the arthropod's prey. Small, slow moving or stationary arthropods have adapted a strategy to instantaneously paralyze their prey by utilizing neurotoxic components of the venom at very low concentrations. These components, or neurotoxins, interfere with the function of insect nervous tissues through efficient competition for certain receptor sites. Many of these neurotoxins are polypeptides. These have been divided into different classes based on their host specificity and mode of action (Zlotkin (1991)
Phytoparasitica
19:177-182). For example, neurotoxic peptides isolated from numerous species of scorpions have been divided into classes that affect arthropods and classes that affect mammals.
Due to a combination of problems associated with some synthetic insecticides, including toxicity, environmental hazards, and loss of efficacy due to resistance, there exists a continuing need for the development of novel means of invertebrate control, including the development of genetically engineered recombinant baculoviruses which express protein toxins capable of incapacitating the host more rapidly than the baculovirus infection per se.
Many different toxins have been isolated from scorpions. Cobatoxin 1 and 2 are potassium channel blocking toxins isolated from scorpions and which have 32 amino acids and contain 3 disulfide bridges (Selisko et al. (1998)
Eur. J. Biochem.
254:468-479). Isolated from scorpion venom, the kaliotoxin 2 precursor contains a 22 amino acid signal sequence and a 37 amino acid mature peptide which specifically binds to receptor sites in rat synaptosomes (Laraba-Djebari et al. (1994)
J. Biol. Chem.
269:32835-32843). Leiuropeptides I, II and III are peptides with cysteine pattern analogous to that of short-chain scorpion toxins. Leiuropeptide I acts on potassium channels, has 31 amino acids and a positively charged region that binds to receptors (Buisine E. et al. (1997)
J. Pept. Res.
49:545-555). Leiurotoxin I is a 31 amino acid peptide with three disulfide bridges holding the amino-terminal alpha structure on the side of the carboxy-terminal two beta barrels (Martins et al. (1990)
FEBS Lett.
260:249-253). The 35 amino acid neurotoxin P2 from the
Androctonus mauretanicus
scorpion is a structural homologue of the so called
Buthus epeus
insect toxins (Rosso and Rochat (1985)
Toxicon
23:113-125). Having 36 residues and some overall homology to charybdotoxin and noxiustoxin, toxin 15-1 blocks calcium-activated potassium currents in muscle fibers (Marshall (1994)
Toxicon
32:1433-1443).
Scorpion venoms have been identified as possible sources of compounds providing insecticidal properties. Two insect-selective toxins isolated from the venom of the scorpion
Leiurus quinquestriatus
and affecting sodium conductance have been reported previously (Zlotkin et al. (1985)
Arch. Biochem. Biophys.
240:877-87). One toxin, AaIT, induced fast excitatory contractive paralysis of fly larvae and the other, LqhIT2, induced slow depressant flaccid paralysis suggesting that these two toxins have different chemical and pharmacological properties (Zlotkin et al. (1971)
Biochimie
(Paris), 53:1073-1078). Thus, other toxins derived from scorpion venom will also have different chemical and pharmacological properties.
SUMMARY OF THE INVENTION
The present invention concerns an isolated polynucleotide comprising a nucleotide sequence selected from the group consisting of: (a) a first nucleotide sequence of at least 81 nucleotides selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, and 19; (b) a second nucleotide sequence encoding a polypeptide of at least 27 amino acids having at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, and 20; or (c) a third nucleotide sequence comprising the complement of the first or second nucleotide sequences.
In a second embodiment, this invention relates to an isolated polynucleotide encoding a mature K-channel agonist.
In a third embodiment, this invention concerns an isolated polynucleotide comprising a nucleotide sequence of at least one of 30 (preferab
Herrmann Rafael
Wong James F.
Benzion Gary
E. I. du Pont de Nemours and Company
Goldberg Jeanine A
LandOfFree
Scorpian toxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Scorpian toxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Scorpian toxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3244878